To model homologous recombination deficiency and evaluate responses to PARP and DNA-PK inhibition, BRCA1 and BRCA2 were individually knocked out in LNCaP cells using CRISPR-Cas9 gene editing (Figure 1D). Here, BRCA2 is linked to hyperinsulinemic hypoglycemia, familial, 4.